Next 10 |
home / stock / sgiof / sgiof news
2024-03-06 14:31:39 ET More on GSK GSK Plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy GSK plc (GSK) Q4 2023 Earnings Call Transcript GSK plc 2023 Q4 - Results - Earnings Call Presentation Guggenheim upgrades GSK to buy from neutral ...
2023-11-01 07:06:02 ET Shionogi & Co., Ltd. (SGIOF) Q2 2023 Earnings Conference Call October 31, 2023, 09:30 PM ET Company Participants Yoshimasa Kyokawa - VP, Corporate Communications Isao Teshirogi - Representative Director, President and CEO Toshinobu Iwas...
2023-09-29 07:16:33 ET More on GSK Merck Vs. GSK: The Game-Changer Race In Pharma Excellence GSK plc (GSK) BofA Global Healthcare Conference (Transcript) GSK plc (GSK) Citi's 18th Annual BioPharma Conference Transcript Wave Life Sciences spikes on R&D Day...
2023-09-05 06:42:18 ET More on Viatris Seeking Alpha’s Quant Rating on Viatris Historical earnings data for Viatris Dividend scorecard for Viatris Financial information for Viatris Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs M...
2023-08-01 13:32:44 ET More on Daiichi Sankyo Daiichi Sankyo Company, Limited ( OTCPK:DSKYF ) Q1 2023 Earnings Call Transcript Shionogi & Co., Ltd. ( OTCPK:SGIOF ) Q1 2023 Earnings Call Transcript Daiichi Sankyo: There Is A Lot Of Room To Grow Dai...
2023-07-31 15:48:40 ET Shionogi & Co. press release ( OTCPK:SGIOF ): Q1 GAAP EPS of ¥144.57. Revenue of ¥109.31B (+52.2% Y/Y). For further details see: Shionogi & Co. GAAP EPS of ¥144.57, revenue of ¥109.31B
2023-05-14 22:31:09 ET Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Conference Call May 10, 2023, 10:00 PM ET Company Participants Yoshimasa Kyokawa - Investor Relations Isao Teshirogi - Chairman and CEO John Keller - Executive Officer, the General Manager o...
2023-05-11 12:44:17 ET Shionogi & Co. ( OTCPK:SGIOF ): FY GAAP EPS of ¥621.31. Revenue of ¥426.7B For further details see: Shionogi & Co. GAAP EPS of ¥621.31, revenue of ¥426.7B
2023-03-30 12:05:56 ET A federal judge on Thursday struck down a key provision in the Affordable Care Act (ACA) that requires health plans to provide free coverage for preventive care, including pre-exposure prophylaxis drugs for HIV (PrEP) and cancer screenings. District Court Judg...
2023-03-30 05:13:16 ET The United Nations-backed Medicines Patent Pool (MPP) signed agreements with Aurobindo, Cipla and Viatris ( NASDAQ: VTRS ) to produce generic versions of ViiV Healthcare's long-acting HIV prevention medicine. ViiV — which is majority o...
News, Short Squeeze, Breakout and More Instantly...